Etoposide-induced apoptosis results in chromosome breaks within the AF9 gene: Its implication in chromosome rearrangement in leukaemia

Cynthia Patricia Nicholas, Sai-Peng Sim

Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Malaysia.

DOI: 10.4236/abb.2012.326089                

Abstract

Treatment with etoposide (VP-16) has been associated with translocation of the mixed lineage leukaemia (MLL) gene seen in treatment-related acute myeloid leukaemia (t-AML). Among the different partner genes, AF9 is the most common partner gene of MLL. AF9 shares similar structural element with the MLL gene. Various mechanisms of translocation have been proposed for the MLL gene, including apoptosis, particularly the apoptotic nuclease. In the current study, we show that VP-16 induced cleavage of the AF9 gene in both leukaemic cells and cultured normal blood cell. All the breakpoints were mapped within the BCR1 of the AF9 gene. AF9 cleavages in leukaemic cells were abolished by pre-treatment with caspase inhibitor (Z-DEVD-FMK), suggesting the involvement of caspase-activated DNase (CAD). The absence of AF9 cleavage in K562 cells further supported the involvement of apoptosis. However, AF9 cleavages in cultured normal blood cell were not eliminated by caspase inhibitor. The possible role of CAD and other apoptotic nucleases/effectors that could be involved in AF9 translocation are discussed.

Keywords

Etoposide (VP-16); Apoptosis; AF9; Chromosome Breaks; Leukaemia

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Ross,W., Rowe,T., Glisson,B., Yalowich,J., & Liu,L. (1984) Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res., 44, 5857-5860.
[2]	Osheroff,N. (1989) Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. Biochemistry, 28, 6157-6160. doi.org/10.1021/bi00441a005
[3]	Felix, C.A. (1998) Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta, 1400, 233-255. doi.org/10.1016/S0167-4781(98)00139-0
[4]	Felix, C.A., Hosler, M.R., Winick, N.J., Masterson, M., Wilson, A.E. and Lange, B.J. (1995) ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood, 85, 3250-3256.
[5]	Super, H.J., McCabe, N.R., Thirman, M.J., Larson, R.A., Le Beau, M.M., Pedersen-Bjergaard, J., Philip, P., Diaz, M.O. and Rowley, J.D. (1993) Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood, 82, 3705-3711.
[6]	Broeker, P.L., Super, H.G., Thirman, M.J., Pomykala, H., Yonebayashi, Y., Tanabe, S., Zeleznik-Le, N. and Rowley, J.D. (1996) Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood, 87, 1912-1922.
[7]	Huret J.L. MLL(myeloid/lymphoid or mixed lineage leukemia). Atlas Genet Cytogenet Oncol Haematol October 2005. http://AtlasGeneticsOncology.org/Genes/MLL.html .
[8]	Nakamura, T., Alder, H., Gu, Y., Prasad, R., Canaani, O., Kamada, N., Gale, R.P., Lange, B., Crist, W.M. and Nowell, P.C. (1993) Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc. Natl. Acad. Sci. U. S. A, 90, 4631-4635. doi.org/10.1073/pnas.90.10.4631
[9]	Super, H.G., Strissel, P.L., Sobulo, O.M., Burian, D., Reshmi, S.C., Roe, B., Zeleznik, L., Diaz, M.O. and Rowley, J.D. (1997) Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes. Cancer, 20, 185-195. doi.org/10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#
[10]	Strissel, P.L., Strick, R., Tomek, R.J., Roe, B.A., Rowley, J.D. and Zeleznik, L. (2000) DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum. Mol Genet., 9, 1671-1679. doi.org/10.1093/hmg/9.11.1671
[11]	Gu, Y., Alder, H., Nakamura, T., Schichman, S.A., Prasad, R., Canaani, O., Saito, H., Croce, C.M. and Canaani, E. (1994) Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Res., 54, 2327-2330.
[12]	Gu, Y., Cimino, G., Alder, H., Nakamura, T., Prasad, R., Canaani, O., Moir,D.T., Jones, C., Nowell, P.C. and Croce, C.M. (1992) The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase. Proc. Natl. Acad. Sci. U. S. A, 89, 10464- 10468. doi.org/10.1073/pnas.89.21.10464
[13]	Strissel, P.L., Strick, R., Rowley, J.D. and Zeleznik, L. (1998) An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood, 92, 3793-3803.
[14]	Sim, S.P. and Liu, L.F. (2001) Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J. Biol. Chem., 276, 31590-31595. doi.org/10.1074/jbc.M103962200
[15]	Sakahira, H., Enari, M., Ohsawa, Y., Uchiyama, Y. and Nagata, S. (1999) Apoptotic nuclear morphological change without DNA fragmentation. Curr. Biol., 9, 543-546. doi.org/10.1016/S0960-9822(99)80240-1
[16]	Vaughan, A.T., Betti, C.J. and Villalobos, M.J. (2002) Surviving apoptosis. Apoptosis., 7, 173-177. doi.org/10.1023/A:1014374717773
[17]	Hars, E.S., Lyu, Y.L., Lin, C.P. and Liu, L.F. (2006) Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia. Cancer Res., 66, 8975-8979. doi.org/10.1158/0008-5472.CAN-06-1724
[18]	Klein,E., Ben Bassat,H., Neumann,H., Ralph,P., Zeuthen,J., Polliack,A., & Vanky,F. (1976) Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int. J. Cancer, 18, 421-431. doi.org/10.1002/ijc.2910180405
[19]	Martins,L.M., Mesner,P.W., Kottke,T.J., Basi,G.S., Sinha,S., Tung,J.S., Svingen,P.A., Madden,B.J., Takahashi,A., McCormick,D.J., Earnshaw,W.C., & Kaufmann,S.H. (1997) Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood, 90, 4283-4296.
[20]	Widlak, P., Li, P., Wang, X. and Garrard, W.T. (2000) Cleavage preferences of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease) on naked DNA and chromatin substrates. J Biol. Chem., 275, 8226-8232. doi.org/10.1074/jbc.275.11.8226
[21]	Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular cloning: a laboratory manual, 2nd edition. Cold Spring Harbor Laboratory, Plainview, New York.
[22]	Watt, J.L.and S.G.S. (1986) Lymphocyte culture for chromosome analysis. In: Rooney, D.E. and Czepulkowski, B.H. Eds., Human cytogenetics: A practical approach, Oxford University Press, USA, 39-55.
[23]	Sakahira, H., Enari, M. and Nagata, S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature, 391, 96-99. doi.org/10.1038/34214
[24]	Hsiang, Y.H., Wu, H.Y. and Liu, L.F. (1988) Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res., 48, 3230-3235.
[25]	Tamai, H. & Inokuchi, K. (2010) 11q23/MLL acute leukemia : update of clinical aspects. J. Clin. Exp. Hematop., 50, 91-98. doi.org/10.3960/jslrt.50.91
[26]	Atlas, M., Head, D., Behm, F., Schmidt, E., Zeleznik, L., Roe, B.A., Burian, D. and Domer, P.H. (1998) Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints. Leukemia, 12, 1895-1902. doi.org/10.1038/sj.leu.2401223
[27]	Odero, M.D., Zeleznik, L., Chinwalla, V. and Rowley, J.D. (2000) Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation. Genes Chromosomes. Cancer, 29, 333-338. doi.org/10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.0.CO;2-Z
[28]	Super, H.J., Martinez-Climent, J. and Rowley, J.D. (1995) Molecular analysis of the Mono Mac 6 cell line: detection of an MLL-AF9 fusion transcript. Blood, 85, 855-856.
[29]	Betti, C.J., Villalobos, M.J., Diaz, M.O. and Vaughan, A.T. (2003) Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division. Cancer Res., 63, 1377-1381.
[30]	Yang, L., Rowe, T.C. and Liu, L.F. (1985) Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells. Cancer Res., 45, 5872-5876.
[31]	Jackson, S.P. (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis, 23, 687-696. doi.org/10.1093/carcin/23.5.687
[32]	Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A. and Nagata, S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature, 391, 43-50. doi.org/10.1038/34112
[33]	Yee, P.H. and Sim, S.P. (2010) High cell density and latent membrane protein 1 expression induce cleavage of the mixed lineage leukemia gene at 11q23 in nasopharyngeal carcinoma cell line. J. Biomed. Sci., 17, 77. doi.org/10.1186/1423-0127-17-77
[34]	Lechardeur, D., Xu, M. and Lukacs, G.L. (2004) Contrasting nuclear dynamics of the caspase-activated DNase (CAD) in dividing and apoptotic cells. J. Cell Biol., 167, 851-862. doi.org/10.1083/jcb.200404105
[35]	Lagarkova, M.A., Iarovaia, O.V. and Razin, S.V. (1995) Large-scale fragmentation of mammalian DNA in the course of apoptosis proceeds via excision of chromosomal DNA loops and their oligomers. J Biol. Chem., 270, 20239-20241. doi.org/10.1074/jbc.270.35.20239
[36]	Kessel, D., Hall, T.C. and Roberts, D. (1968) Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response. Cancer Res., 28, 564-570.
[37]	Lyons, R.M. and Goldenberg, G.J. (1972) Active transport of nitrogen mustard and choline by normal and leukemic human lymphoid cells. Cancer Res., 32, 1679-1685.
[38]	Kim, D.K., Cho, E.S. and Um, H.D. (2000) Caspase-dependent and-independent events in apoptosis induced by hydrogen peroxide. Exp. Cell Res., 257, 82-88. doi.org/10.1006/excr.2000.4868
[39]	Kitagawa, K. and Niikura, Y. (2008) Caspase-independent mitotic death (CIMD). Cell Cycle, 7, 1001-1005. doi.org/10.4161/cc.7.8.5720
[40]	Samejima, K., Tone, S. and Earnshaw, W.C. (2001) CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis. J Biol. Chem., 276, 45427-45432. doi.org/10.1074/jbc.M108844200
[41]	Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E., Brothers, G.M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D.R., Aebersold, R., Siderovski, D.P., Penninger, J.M. and Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-446. doi.org/10.1038/17135
[42]	Li, L.Y., Luo, X. and Wang, X. (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 412, 95-99. doi.org/10.1038/35083620
[43]	van Loo, G., Schotte, P., van Gurp, M., Demol, H., Hoorelbeke, B., Gevaert, K., Rodriguez, I., Ruiz-Carrillo, A., Vandekerckhove, J., Declercq, W., Beyaert, R. and Vandenabeele, P. (2001) Endonuclease G: a mitochondrial protein released in apoptosis and involved in cas-pase-independent DNA degradation. Cell Death. Differ., 8, 1136-1142. doi.org/10.1038/sj.cdd.4400944
[44]	Widlak, P., Li, L.Y., Wang, X. and Garrard, W.T. (2001) Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J. Biol. Chem., 276, 48404-48409.
[45]	Strick, R., Strissel, P.L., Borgers, S., Smith, S.L. and Rowley, J.D. (2000) Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. U. S. A, 97, 4790-4795. doi.org/10.1073/pnas.070061297
[46]	Solovyan, V.T., Bezvenyuk, Z.A., Salminen, A., Austin, C.A. and Courtney, M.J. (2002) The role of topoisomerase II in the excision of DNA loop domains during apoptosis. J Biol. Chem., 277, 21458-21467. doi.org/10.1074/jbc.M110621200
[47]	Earnshaw, W.C., Halligan, B., Cooke, C.A., Heck, M.M. and Liu, L.F. (1985) Topoisomerase II is a structural component of mitotic chromosome scaffolds. J. Cell Biol., 100, 1706-1715. doi.org/10.1083/jcb.100.5.1706
[48]	Durrieu, F., Samejima, K., Fortune, J.M., Kandels-Lewis, S., Osheroff, N. and Earnshaw, W.C. (2000) DNA topoisomerase IIalpha interacts with CAD nuclease and is involved in chromatin condensation during apoptotic execution. Curr. Biol., 10, 923-926. doi.org/10.1016/S0960-9822(00)00620-5
[49]	Laemmli, U.K., Kas, E., Poljak, L. and Adachi, Y. (1992) Scaffold-associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr. Opin. Genet. Dev., 2, 275-285. doi.org/10.1016/S0959-437X(05)80285-0.